Literature DB >> 26604026

Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease.

R A Underhill.   

Abstract

The etiology of myalgic encephalomyelitis also known as chronic fatigue syndrome or ME/CFS has not been established. Controversies exist over whether it is an organic disease or a psychological disorder and even the existence of ME/CFS as a disease entity is sometimes denied. Suggested causal hypotheses have included psychosomatic disorders, infectious agents, immune dysfunctions, autoimmunity, metabolic disturbances, toxins and inherited genetic factors. Clinical, immunological and epidemiological evidence supports the hypothesis that: ME/CFS is an infectious disease; the causal pathogen persists in patients; the pathogen can be transmitted by casual contact; host factors determine susceptibility to the illness; and there is a population of healthy carriers, who may be able to shed the pathogen. ME/CFS is endemic globally as sporadic cases and occasional cluster outbreaks (epidemics). Cluster outbreaks imply an infectious agent. An abrupt flu-like onset resembling an infectious illness occurs in outbreak patients and many sporadic patients. Immune responses in sporadic patients resemble immune responses in other infectious diseases. Contagion is shown by finding secondary cases in outbreaks, and suggested by a higher prevalence of ME/CFS in sporadic patients' genetically unrelated close contacts (spouses/partners) than the community. Abortive cases, sub-clinical cases, and carrier state individuals were found in outbreaks. The chronic phase of ME/CFS does not appear to be particularly infective. Some healthy patient-contacts show immune responses similar to patients' immune responses, suggesting exposure to the same antigen (a pathogen). The chronicity of symptoms and of immune system changes and the occurrence of secondary cases suggest persistence of a causal pathogen. Risk factors which predispose to developing ME/CFS are: a close family member with ME/CFS; inherited genetic factors; female gender; age; rest/activity; previous exposure to stress or toxins; various infectious diseases preceding the onset of ME/CFS; and occupational exposure of health care professionals. The hypothesis implies that ME/CFS patients should not donate blood or tissue and usual precautions should be taken when handling patients' blood and tissue. No known pathogen has been shown to cause ME/CFS. Confirmation of the hypothesis requires identification of a causal pathogen. Research should focus on a search for unknown and known pathogens. Finding a causal pathogen could assist with diagnosis; help find a biomarker; enable the development of anti-microbial treatments; suggest preventive measures; explain pathophysiological findings; and reassure patients about the validity of their symptoms.

Entities:  

Mesh:

Year:  2016        PMID: 26604026     DOI: 10.1016/j.mehy.2015.10.011

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  26 in total

1.  Patient perceptions of infectious illnesses preceding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Leonard A Jason; Samuel Yoo; Shaun Bhatia
Journal:  Chronic Illn       Date:  2021-09-20

Review 2.  The Role of Kynurenine Pathway and NAD+ Metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Mona Dehhaghi; Hamed Kazemi Shariat Panahi; Bahar Kavyani; Benjamin Heng; Vanessa Tan; Nady Braidy; Gilles J Guillemin
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

3.  Cardiovascular characteristics of chronic fatigue syndrome.

Authors:  Sara Bozzini; Andrea Albergati; Enrica Capelli; Lorenzo Lorusso; Carmine Gazzaruso; Gabriele Pelissero; Colomba Falcone
Journal:  Biomed Rep       Date:  2017-11-28

4.  Human Herpesvirus 6 Infection and Risk of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Sayed-Hamidreza Mozhgani; Farid Rajabi; Mohsen Qurbani; Yousef Erfani; Somayeh Yaslianifard; Azam Moosavi; Kiomars Pourrostami; Ali Baradaran Bagheri; Alireza Soleimani; Farida Behzadian; Mahshid Safavi; Farhad Rezaei
Journal:  Intervirology       Date:  2021-06-23       Impact factor: 1.763

5.  Factors impacting the illness trajectory of post-infectious fatigue syndrome: a qualitative study of adults' experiences.

Authors:  Eva Stormorken; Leonard A Jason; Marit Kirkevold
Journal:  BMC Public Health       Date:  2017-12-13       Impact factor: 3.295

6.  XMRV and Public Health: The Retroviral Genome Is Not a Suitable Template for Diagnostic PCR, and Its Association with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Appears Unreliable.

Authors:  Simona Panelli; Lorenzo Lorusso; Alessandro Balestrieri; Giuseppe Lupo; Enrica Capelli
Journal:  Front Public Health       Date:  2017-05-22

Review 7.  Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?

Authors:  Fiona Newberry; Shen-Yuan Hsieh; Tom Wileman; Simon R Carding
Journal:  Clin Sci (Lond)       Date:  2018-03-09       Impact factor: 6.124

Review 8.  Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.

Authors:  Jonas Blomberg; Carl-Gerhard Gottfries; Amal Elfaitouri; Muhammad Rizwan; Anders Rosén
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

9.  Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank.

Authors:  Tiago Dias Domingues; Anna D Grabowska; Ji-Sook Lee; Jose Ameijeiras-Alonso; Francisco Westermeier; Carmen Scheibenbogen; Jacqueline M Cliff; Luis Nacul; Eliana M Lacerda; Helena Mouriño; Nuno Sepúlveda
Journal:  Front Med (Lausanne)       Date:  2021-07-05

10.  A preliminary investigation of nutritional intake and supplement use in Australians with myalgic encephalomyelitis/chronic fatigue syndrome and the implications on health-related quality of life.

Authors:  Breanna Weigel; Natalie Eaton-Fitch; Rachel Passmore; Hélène Cabanas; Donald Staines; Sonya Marshall-Gradisnik
Journal:  Food Nutr Res       Date:  2021-06-07       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.